NCT07093281View on ClinicalTrials.gov

Intranasal LAIV Mucosal Immunity Examination

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2026

Conditions

Impact of Vaccination

Interventions

BIOLOGICAL

Live Attenuated Influenza Vaccine

Nasal spray

Trial Locations (1)

21231

University of Maryland Medical Center, Baltimore

All Listed Sponsors

lead

University of Maryland, Baltimore

OTHER